A critical discovery in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in many types of cancer, https://alphabookmarking.com/story21798473/mini-antibodies-restore-the-p53-protein-new-potential-hope-for-tumor-treatment